Message: |
1. Basic Information
Product name:cb-03-01
Other name:Cortexolone 17α-propionate ,11-deoxycortisol 17α-propionate
CAS: 19608-29-8
MF: C24H34O5
MW: 402.52
Appearance:white powder
Purity:99%
Test Method: HPLC
Packaging Details:10g,20g,50g,100g,500g,1kg,10kg
Payment:Bitcoin,Moneygram and Wester Union
Lead time:24hours after received payment
Cb0301 (breezula) may be a new reasonably phalacrosis treatment compound, which may block the mix of sex hormone and its receptor. The treatment of male phalacrosis won't scale back the sex hormone within the body, however through interference the mix of sex hormone and its receptor to treat male phalacrosis, that is presently in clinical trials.
Specific indicators of our products:
2. Price
Quantity Specifications Unit Price
5g 99% 347usd
50g 99% 2316usd
100g 99% 3475usd
We area unit a manufacturer, if you're to produce alternative customers, every time you buy massive enough, we are able to offer you a more robust worth.
3.Effect and evaluation
Clinical results showed that cb-0301 had a positive result on male hair loss, and also the best result was to use seven.5% cb0301 doubly daily. For the protection analysis of cb0301, there have been no general aspect effects. Cb-0301 may be a new, safe and effective external opposing sex hormone programme, which may be wont to treat and stabilize male hair loss. For grade three, four and five phalacrosis patients, cb-0301 has sure result when treatment. there's an enormous demand within the international hair loss trade, and also the existing treatment ways area unit removed from meeting the demand. If the merchandise is approved, it'll bring hope to several patients. If cb-0301 is approved by federal agency, it'll be the primary topical opposing sex hormone drug since its launch in 1997. |